<H1>Chapter DOI: 10.1186/s12879-016-1592-1<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>32</td></tr><tr><td>Springer references</td><td>5</td></tr><tr><td>Non Springer references</td><td>27</td></tr><tr><td>BibStructured Count</td><td width="10%">28</td></tr><tr><td>BibUnstructured Count</td><td width="10%">4</td></tr><tr><td>DOI already available in SpringerLink</td><td>26</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Vitrat V, Hautefeuille S, Janssen C, Bougon D, Sirodot M, Pagani L. Optimizing antimicrobial therapy in critically ill patients. Infect Drug Resist. 2014;7:261&#8211;71.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.2147/idr.s44357>10.2147/idr.s44357</a></td><td><b>CrossRef-Web</b></td>
<td>ArticleTitle, Year, FirstPage</td><td>CrossRef</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Textoris J, Wiramus S, Martin C, Leone M. Overview of antimicrobial therapy in intensive care units. Expert Rev Anti Infect Ther. 2011;9:97&#8211;109.</td><td><a href=http://dx.doi.org/10.1586/eri.10.147>10.1586/eri.10.147</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Weinstein RA. Nosocomial infection up-date. Emerg Infect Dis. 1998;4:416&#8211;20.</td><td><a href=http://dx.doi.org/10.3201/eid0403.980320>10.3201/eid0403.980320</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Vincent</span> <span style='background:#DDDDDD'>JL</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Rello</span> <span style='background:#DDDDDD'>J</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Marshall</span> <span style='background:#DDDDDD'>J</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Silva</span> <span style='background:#DDDDDD'>E</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Anzueto</span> <span style='background:#DDDDDD'>A</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Martin</span> <span style='background:#DDDDDD'>CD</span></span>, et al.</aug> <span style='background:#CCCCFF'>EPIC II Group of Investigators International study of the prevalence and outcomes of infection in intensive care units</span>. <span style='background:#CCFF99'>JAMA</span>. <span style='background:#66FF66'>2009</span>;<span style='background:#FFCC66'>302</span>:<span style='background:#D279FF'>2323&#8211;9</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Aly NY, Al-Mousa HH, el Al Asar SM. Nosocomial infections in a medical-surgical intensive care unit. Med Princ Pract. 2008;17:373&#8211;7.</td><td><a href=http://dx.doi.org/10.1159/000141500>10.1159/000141500</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Montassier E, Batard E, Gastinne T, Potel G, de la Cocheti&#232;re MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32:841&#8211;50.</td><td><a href=http://dx.doi.org/10.1007/s10096-013-1819-7>10.1007/s10096-013-1819-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Neidell NJ, Cohen B, Furuya Y, Hill J, Jeon CY, Glied S, et al. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012;55:807&#8211;15.</td><td><a href=http://dx.doi.org/10.1093/cid/cis552>10.1093/cid/cis552</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2011;134:298&#8211;314.</td><td><a href=http://dx.doi.org/10.7326/0003-4819-134-4-200102200-00014>10.7326/0003-4819-134-4-200102200-00014</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Kostakou E, Rovina N, Kyriakopoulou M, Koulouris NG, Koutsoukou A. Critically ill cancer patient in intensive care unti: issues that arise. J Crit Care. 2014;29:817&#8211;22.</td><td><a href=http://dx.doi.org/10.1016/j.jcrc.2014.04.007>10.1016/j.jcrc.2014.04.007</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>Clinical and Laboratory Standards Institute (CLSI)</span>: <span style='background:#FFD9B3'>Performance standards for antimicrobial susceptibility testing. Approved Standard M100-S23</span>. <span style='background:#C0FFC0'>Wayne, PA</span>: <span style='background:#FFFF49'>Clinical and Laboratory Standards Institute</span>; <span style='background:#66FF66'>2013</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CE, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268&#8211;81.</td><td><a href=http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x>10.1111/j.1469-0691.2011.03570.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>CDC/NHSN Surveillance Definition of Healthcare-Associated Infection and Criteria for Specific Types of Infections in the Acute Care Setting. January</span> <span style='background:#66FF66'>2015</span>. <span style='background:#FF3300'>www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf</span>. <span style='background:#FFFF0F'>Accessed 15 Feb 2015</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Ariza-Heredia EJ, Chemaly RF. Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges. Cl Lymph Myelom Leuk. 2014;14(Suppl):104&#8211;10.</td><td><a href=http://dx.doi.org/10.1016/j.clml.2014.06.021>10.1016/j.clml.2014.06.021</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Namendys-Silva SA, Texcocano-Becerra J, Herrera-G&#243;mez A. Prognostic factors in critically ill patients with solid tumours admitted to an oncological intensive care unit. Anaesth Intensive Care. 2010;38:317&#8211;24.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Unseld S, Schuepbach RA, Maggiorini M. ICU, hospital and one year mortality of patients suffering from solid or haematological malignancies. Swiss Med Wkly. 2013;143:w13741. doi: 10.4414/smw.2013.13741.</td><td><a href=http://dx.doi.org/10.4414/smw.2013.13741>10.4414/smw.2013.13741</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Song JU, Suh GY, Chung MP, Kim H, Kwon OJ, Jung CW, Kang WK, Park K, Jeon K. Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer. 2011;19:491&#8211;5.</td><td><a href=http://dx.doi.org/10.1007/s00520-010-0841-x>10.1007/s00520-010-0841-x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Aygencel G, Turkoglu M, Turkoz Sucak G, Benekli M. Prognostic factors in critically ill cancer patients admitted to the intensive care unit. J Crit Care. 2014;29:618&#8211;26.</td><td><a href=http://dx.doi.org/10.1016/j.jcrc.2014.01.014>10.1016/j.jcrc.2014.01.014</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Sammon J, Trinh VQ, Ravi P, Sukumar S, Gervais MK, Shariat SF, et al. Health care-associated infections after major cancer surgery: temporal trends, patterns of care, and effect on mortality. Cancer. 2013;119:2317&#8211;24.</td><td><a href=http://dx.doi.org/10.1002/cncr.28027>10.1002/cncr.28027</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Dereli N, Ozayar E, Degerli S, Sahin S, Ko&#231; F. Three-year evaluation of nosocomial infection rates of the ICU. Rev Bras Anesthesiol. 2013;63:73&#8211;84.</td><td><a href=http://dx.doi.org/10.1016/S0034-7094(13)70199-5>10.1016/S0034-7094(13)70199-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145:582&#8211;91.</td><td><a href=http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00007>10.7326/0003-4819-145-8-200610170-00007</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Coffin SE, Komplas M, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 31:31&#8211;40.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006&#8211;2007. Infect Control Hosp Epidemiol. 2008;29:996&#8211;1011.</td><td><a href=http://dx.doi.org/10.1086/591861>10.1086/591861</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Wagenlehner FM, Weidner W, Naber KG. Emergence of antibiotic resistance amongst hospital-acquired urinary tract infections and pharmacokinetic/pharmacodynamics considerations. J Hosp Infect. 2005;60:191&#8211;200.</td><td><a href=http://dx.doi.org/10.1016/j.jhin.2004.12.017>10.1016/j.jhin.2004.12.017</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>DiGiorgio MJ, Fatica C, Oden M, Bolwell B, Sekeres M, Kalaycio M, et al. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2012;33:865&#8211;8.</td><td><a href=http://dx.doi.org/10.1086/667380>10.1086/667380</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Volkow P, Sanchez-Mejorada G, de la Vega SL, Vazquez C, Tellez O, Baez RM, et al. Experience of an intravenous therapy team at the Instituto Nacional de Cancerologia (mexico) with a long-lasting, low-cost silastic venous catheter. Clin Infect Dis. 1994;18:719&#8211;25.</td><td><a href=http://dx.doi.org/10.1093/clinids/18.5.719>10.1093/clinids/18.5.719</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Volkow P, V&#225;zquez C, T&#233;llez O, Aguilar C, Barrera L, Rodr&#237;guez E, et al. Polyurethane II catheter as long-indwelling intravenous catheter in patients with cancer. Am J Infect Control. 2003;31:392&#8211;6.</td><td><a href=http://dx.doi.org/10.1067/mic.2003.39>10.1067/mic.2003.39</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Morfin-Otero R, Noriega ER, Dowzicky MJ. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial. Ann Clin Microbiol Antimicrob. 2015;14:53. doi: 10.1186/s12941-015-0116-y.</td><td><a href=http://dx.doi.org/10.1186/s12941-015-0116-y>10.1186/s12941-015-0116-y</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Gales AC, Castanheira M, Jones RN, Sader HS. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008&#8211;2010). Diagn Microbiol Infect Dis. 2012;73:354&#8211;60.</td><td><a href=http://dx.doi.org/10.1016/j.diagmicrobio.2012.04.007>10.1016/j.diagmicrobio.2012.04.007</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Morfin-Otero R, Tinoco-Favila JC, Sader HS, Salcido-Gutierrez L, Perez-Gomez HR, Gonzalez-Diaz E, Petersen L, Rodriguez-Noriega E. Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005&#8211;2010. BMC Res Notes. 2012;5:277. doi: 10.1186/1756-0500-5-277.</td><td><a href=http://dx.doi.org/10.1186/1756-0500-5-277>10.1186/1756-0500-5-277</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Schwaber</span> <span style='background:#DDDDDD'>MJ</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Carmeli</span> <span style='background:#DDDDDD'>Y.</span></span></aug> <span style='background:#CCCCFF'>The effect of antimicrobial resistance on patient outcomes: importance of proper evaluation of appropriate therapy. (Abstract)</span>. <span style='background:#CCFF99'>Crit Care</span>. <span style='background:#66FF66'>2009</span>; <span style='background:#FFFF0F'>doi:10.1186/cc7136. Epub 2009 Jan 12</span>.</td><td><a href=http://dx.doi.org/10.1186/cc7136>10.1186/cc7136</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Cornejo-Ju&#225;rez P, Vilar-Compte D, P&#233;rez-Jim&#233;nez C, &#209;amendys-Silva SA, Sandoval-Hern&#225;ndez S, Volkow-Fern&#225;ndez P. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infec Dis. 2015;31:31&#8211;4.</td><td><a href=http://dx.doi.org/10.1016/j.ijid.2014.12.022>10.1016/j.ijid.2014.12.022</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Llaca-D&#237;az JM, Mendoza-Olazar&#225;n S, Camacho-Ortiz A, Flores S, Garza-Gonz&#225;lez E. One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey Mexico. Chemotherapy. 2012;58:475&#8211;81.</td><td><a href=http://dx.doi.org/10.1159/000346352>10.1159/000346352</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>